{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:36:41Z","timestamp":1791041801074,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>\n            Heterogeneity among aldosterone-producing adenomas (APAs) has been highlighted by the discovery of somatic mutations.\n            <jats:italic>KCNJ5<\/jats:italic>\n            mutations predominate in large zona fasciculata (ZF)\u2013like APAs; mutations in\n            <jats:italic>CACNA1D<\/jats:italic>\n            ,\n            <jats:italic>ATP1A1, ATP2B3<\/jats:italic>\n            , and\n            <jats:italic>CTNNB1<\/jats:italic>\n            are more likely to be found in small zona glomerulosa (ZG)\u2013like APAs. Microarray comparison of\n            <jats:italic>KCNJ5<\/jats:italic>\n            mutant versus wild-type APAs revealed significant differences in transcriptomes.\n            <jats:italic>NEFM<\/jats:italic>\n            , encoding a neurofilament subunit which is a D1R (dopamine D1 receptor)\u2013interacting protein, was 4-fold upregulated in ZG-like versus ZF-like APAs and 14-fold more highly expressed in normal ZG versus ZF. Immunohistochemistry confirmed selective expression of NEFM (neurofilament medium) polypeptide in ZG and in ZG-like APAs. Silencing\n            <jats:italic>NEFM<\/jats:italic>\n            in adrenocortical H295R cells increased basal aldosterone secretion and cell proliferation; silencing also amplified aldosterone stimulation by the D1R agonist, fenoldopam, and inhibition by the D1R antagonist, SCH23390. NEFM coimmunoprecipitated with D1R, and its expression was stimulated by fenoldopam. Immunohistochemistry for D1R was mainly intracellular in ZG-like APAs but membranous in ZF-like APAs. Aldosterone secretion in response to fenoldopam in primary cells from ZF-like APAs was higher than in cells from ZG-like APAs. Transfection of mutant KCNJ5 caused a large reduction in NEFM expression in H295R cells. We conclude that NEFM is a negative regulator of aldosterone production and cell proliferation, in part by facilitating D1R internalization from the plasma membrane. Downregulation of NEFM in ZF-like APAs may contribute to a D1R\/D2R imbalance underlying variable pharmacological responses to dopaminergic drugs among patients with APAs. Finally, taken together, our data point to the possibility that ZF-like APAs are in fact ZG in origin.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.117.09231","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:50:12Z","timestamp":1496710212000},"page":"357-364","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)\u2013Mediated Secretion of Aldosterone"],"prefix":"10.1161","volume":"70","author":[{"given":"Carmela","family":"Maniero","sequence":"first","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Garg","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Isaac","family":"Johnson","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhou","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris J.","family":"Brown","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke\u2019s Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2550"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504869"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06186"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.186239"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.3.7883831"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/3.6.93S"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002642"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1090339"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198604000-00010"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.9.7859"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2338"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1530\/JME-13-0044"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.3.4992"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068925"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031746"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1310091"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1734"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000025"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08033"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198900148-00004"},{"issue":"4","key":"e_1_3_4_25_2","first-page":"E431","article-title":"Dopamine 3-sulfate inhibits aldosterone secretion in cultured bovine adrenal cells.","volume":"247","author":"R\u00e1cz K","year":"1984","unstructured":"R\u00e1cz K, Buu NT, Kuchel O, De L\u00e9an A. Dopamine 3-sulfate inhibits aldosterone secretion in cultured bovine adrenal cells. Am J Physiol. 1984;247(4 pt 1):E431\u2013E435.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2965"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.12.023"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7569904"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-14-05920.2002"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.45"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2015.1050173"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-015-2516-x"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.181"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-5-16"},{"key":"e_1_3_4_35_2","first-page":"754","article-title":"Sequential responses of the renin-angiotensin-aldosterone axis to acute postural change: effect of dietary sodium.","volume":"86","author":"Tuck ML","year":"1975","unstructured":"Tuck ML, Dluhy RG, Williams GH. Sequential responses of the renin-angiotensin-aldosterone axis to acute postural change: effect of dietary sodium. J Lab Clin Med. 1975;86:754\u2013763.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb01021.x"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-59-3-360"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.117.09231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:02:42Z","timestamp":1715590962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.117.09231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.117.09231"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.117.09231","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"2017-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}